However, in a mouse model of CRC carrying the p53 R270H mutant, p53mut/− mice showed similar tumor burden, metastasis frequency, and overall survival to p53−/− mice arguing against p53 GOF [83]. This evidence concerns the gene TP53 and colorectal carcinoma.